Related Experiment Video
Updated: Jun 27, 2026

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
Published on: February 5, 2015
Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue
Barbara Serafini1, Roberta Magliozzi, Barbara Rosicarelli
1Department of Cell Biology and Neuroscience, Istituto Superiore di Sanità, Rome, Italy.
Abstract:
The expression patterns of tumor necrosis factor-like weak inducer of apoptosis (TWEAK), a pleiotropic cytokine with proinflammatory and cell death-inducing activities, and its receptor, fibroblast growth factor-inducible 14 (Fn14), were examined in postmortem brain tissue samples from patients with multiple sclerosis (MS) and controls. Immunohistochemical analysis and real-time reverse transcription-polymerase chain reaction demonstrated that both TWEAK and Fn14 were upregulated in the MS compared with control unaffected brain samples. Perivascular and meningeal macrophages and astrocytes and microglia associated with lesions were identified as the main sources of TWEAK in the MS brains. The highest frequency of TWEAK+ cells was found at edges of chronic active white matter lesions and in subpial cortical lesions inMS cases with abundant meningeal inflammation and ectopic B-cell follicles. Neurons and reactive astrocytes expressing Fn14 were mainly localized in the cerebral cortex in highly infiltrated MS brains. Numerous TWEAK-expressing microglia were associated with the extensive loss of myelin and astrocytosis, neuronal damage, and vascular abnormalities in subpial cortical lesions; this suggests that TWEAK could synergize with other cytotoxic factors diffusing from the inflamed meninges to promote cortical injury. Taken together, these findings indicate that the TWEAK/Fn14 pathway contributes to inflammation and tissue injury and is, therefore, a potential therapeutic target in MS.
Insights
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor (Fn14) are upregulated in multiple sclerosis (MS) brain tissue. This TWEAK/Fn14 pathway indicates a potential therapeutic target for MS inflammation and injury.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.
- The role of specific inflammatory cytokines and their receptors in MS pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate the expression patterns of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 (Fn14), in postmortem brain tissue from MS patients and controls.
- To determine the cellular sources and localization of TWEAK and Fn14 in relation to MS lesions and neuropathology.
Main Methods:
- Immunohistochemistry was employed to visualize TWEAK and Fn14 expression in brain tissue.
- Real-time reverse transcription-polymerase chain reaction (RT-PCR) was used to quantify gene expression levels.
- Analysis was performed on postmortem brain samples from individuals with MS and healthy controls.
Main Results:
- Both TWEAK and Fn14 expression were significantly upregulated in MS brain tissue compared to controls.
- TWEAK was primarily expressed by macrophages, astrocytes, and microglia associated with MS lesions, particularly at the edges of active white matter lesions and in cortical lesions.
- Fn14 was predominantly found on neurons and reactive astrocytes in the cerebral cortex of MS brains.
Conclusions:
- The TWEAK/Fn14 pathway is implicated in the inflammatory processes and tissue damage observed in multiple sclerosis.
- Upregulation of TWEAK and Fn14 suggests this pathway is a potential therapeutic target for managing MS.
- TWEAK may synergize with other factors to drive cortical injury in MS, especially in cases with meningeal inflammation.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Multiple Sclerosis l: Introduction
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Tissue Injury: Inflammation and Repair
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...

